Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1991 Mar;138(3):707–719.

The effects of monocrotaline pyrrole on cultured bovine pulmonary artery endothelial and smooth muscle cells.

J F Reindel 1, R A Roth 1
PMCID: PMC1886276  PMID: 2000943

Abstract

Monocrotaline pyrrole (MCTP), a reactive electrophile, induces delayed and progressive pulmonary edema, vascular remodeling, and pulmonary hypertension after a single intravenous administration to rats. The effects of a single exposure of cultured bovine pulmonary artery endothelial cells (BEC) and bovine pulmonary artery smooth muscle cells (BSMC) to MCTP were examined. Monocrotaline pyrrole caused a dose-dependent, delayed, and progressive cell detachment and release of lactate dehydrogenase activity from monolayers of BECs but not BSMCs. Monolayers of BECs also released increased concentrations of 6-keto-prostaglandin F1 degrees, the stable metabolite of prostacyclin, as the post-treatment interval increased. Progressive and marked endothelial cell hypertrophy occurred after exposure to a nominal concentration of 5 or 50 micrograms/ml of MCTP but not after 0.5 micrograms/ml. Morphologic changes in monolayers of BSMCs were minimal, even up to 2 weeks after exposure. Ultrastructurally the hypertrophic, MCTP-treated BECs had enlarged cell profiles with enlarged nuclei. The nucleoli were prominent, occasionally multiple, and had separation of granular and fibrillar components. Cytoplasmic microtubules and perinuclear intermediate filaments were prominent in some cells, as were the golgi apparatus and endoplasmic reticulum. Degenerative changes were not prominent in cells that remained in the monolayer. Monocrotaline pyrrole inhibited proliferation of both cell types at concentrations (0.5 micrograms/ml) that were not cytotoxic. These findings indicate that MCTP induces direct, dose-dependent injury to cells in culture that is delayed and progressive, and the expression of this injury depends, in part, on the cell type.

Full text

PDF
707

Images in this article

711Figure 1
on p.711
712Figure 2
on p.712
713Figure 4
on p.713

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARNES J. M., MAGEE P. N., SCHOENTAL R. LESIONS IN THE LUNGS AND LIVERS OF RATS POISONED WITH THE PYRROLIZIDINE ALKALOID FULVINE AND ITS N-OXIDE. J Pathol Bacteriol. 1964 Oct;88:521–531. doi: 10.1002/path.1700880215. [DOI] [PubMed] [Google Scholar]
  2. Bruner L. H., Carpenter L. J., Hamlow P., Roth R. A. Effect of a mixed function oxidase inducer and inhibitor on monocrotaline pyrrole pneumotoxicity. Toxicol Appl Pharmacol. 1986 Sep 30;85(3):416–427. doi: 10.1016/0041-008x(86)90349-2. [DOI] [PubMed] [Google Scholar]
  3. Bruner L. H., Hilliker K. S., Roth R. A. Pulmonary hypertension and ECG changes from monocrotaline pyrrole in the rat. Am J Physiol. 1983 Aug;245(2):H300–H306. doi: 10.1152/ajpheart.1983.245.2.H300. [DOI] [PubMed] [Google Scholar]
  4. Butler W. H., Mattocks A. R., Barnes J. M. Lesions in the liver and lungs of rats given pyrrole derivatives of pyrrolizidine alkaloids. J Pathol. 1970 Mar;100(3):169–175. doi: 10.1002/path.1711000305. [DOI] [PubMed] [Google Scholar]
  5. Butler W. H., Mattocks A. R., Barnes J. M. Lesions in the liver and lungs of rats given pyrrole derivatives of pyrrolizidine alkaloids. J Pathol. 1970 Mar;100(3):169–175. doi: 10.1002/path.1711000305. [DOI] [PubMed] [Google Scholar]
  6. Chesney C. F., Allen J. R., Hsu I. C. Right ventricular hypertrophy in monocrotaline pyrrole treated rats. Exp Mol Pathol. 1974 Apr;20(2):257–268. doi: 10.1016/0014-4800(74)90058-6. [DOI] [PubMed] [Google Scholar]
  7. Coflesky J. T., Adler K. B., Woodcock-Mitchell J., Mitchell J., Evans J. N. Proliferative changes in the pulmonary arterial wall during short-term hyperoxic injury to the lung. Am J Pathol. 1988 Sep;132(3):563–573. [PMC free article] [PubMed] [Google Scholar]
  8. Downing D. T., Peterson J. E. Quantitative assessment of the persistent antimitotic effect of certain hepatotoxic pyrrolizidine alkaloids on rat liver. Aust J Exp Biol Med Sci. 1968 Oct;46(5):493–502. doi: 10.1038/icb.1968.157. [DOI] [PubMed] [Google Scholar]
  9. Fantone J. C., Kunkel R. G., Kinnes D. A. Potentiation of alpha-naphthyl thiourea-induced lung injury by prostaglandin E1 and platelet depletion. Lab Invest. 1984 Jun;50(6):703–710. [PubMed] [Google Scholar]
  10. Ghodsi F., Will J. A. Changes in pulmonary structure and function induced by monocrotaline intoxication. Am J Physiol. 1981 Feb;240(2):H149–H155. doi: 10.1152/ajpheart.1981.240.2.H149. [DOI] [PubMed] [Google Scholar]
  11. Harlan J. M., Harker L. A., Reidy M. A., Gajdusek C. M., Schwartz S. M., Striker G. E. Lipopolysaccharide-mediated bovine endothelial cell injury in vitro. Lab Invest. 1983 Mar;48(3):269–274. [PubMed] [Google Scholar]
  12. Hilliker K. S., Bell T. G., Roth R. A. Pneumotoxicity and thrombocytopenia after single injection of monocrotaline. Am J Physiol. 1982 Apr;242(4):H573–H579. doi: 10.1152/ajpheart.1982.242.4.H573. [DOI] [PubMed] [Google Scholar]
  13. Hilliker K. S., Garcia C. M., Roth R. A. Effects of monocrotaline and monocrotaline pyrrole on 5-hydroxytryptamine and paraquat uptake by lung slices. Res Commun Chem Pathol Pharmacol. 1983 May;40(2):179–197. [PubMed] [Google Scholar]
  14. Hurley J. V., Jago M. V. Pulmonary oedema in rats given dehydromonocrotaline: a topographic and electron-microscope study. J Pathol. 1975 Sep;117(1):23–32. doi: 10.1002/path.1711170104. [DOI] [PubMed] [Google Scholar]
  15. Jaffe E. A., Nachman R. L., Becker C. G., Minick C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973 Nov;52(11):2745–2756. doi: 10.1172/JCI107470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Jago M. V. The development of the hepatic megalocytosis of chronic pyrrolizidine alkaloid poisoning. Am J Pathol. 1969 Sep;56(3):405–421. [PMC free article] [PubMed] [Google Scholar]
  17. Jones R., Zapol W. M., Reid L. Pulmonary artery remodeling and pulmonary hypertension after exposure to hyperoxia for 7 days. A morphometric and hemodynamic study. Am J Pathol. 1984 Nov;117(2):273–285. [PMC free article] [PubMed] [Google Scholar]
  18. Lalich J. L., Johnson W. D., Raczniak T. J., Shumaker R. C. Fibrin thrombosis in monocrotaline pyrrole-induced cor pulmonale in rats. Arch Pathol Lab Med. 1977 Feb;101(2):69–73. [PubMed] [Google Scholar]
  19. Langleben D., Reid L. M. Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy. Lab Invest. 1985 Mar;52(3):298–303. [PubMed] [Google Scholar]
  20. Mattocks A. R. Dihydropyrrolizine derivatives from unsaturated pyrrolizidine alkaloids. J Chem Soc Perkin 1. 1969;8:1155–1162. doi: 10.1039/j39690001155. [DOI] [PubMed] [Google Scholar]
  21. Mattocks A. R. Toxicity of pyrrolizidine alkaloids. Nature. 1968 Feb 24;217(5130):723–728. doi: 10.1038/217723a0. [DOI] [PubMed] [Google Scholar]
  22. Mattocks A. R., White I. N. The conversion of pyrrolizidine alkaloids to N-oxides and to dihydropyrrolizine derivatives by rat-liver microsomes in vitro. Chem Biol Interact. 1971 Oct;3(5):383–396. doi: 10.1016/0009-2797(71)90018-4. [DOI] [PubMed] [Google Scholar]
  23. Meyrick B. O. Endotoxin-mediated pulmonary endothelial cell injury. Fed Proc. 1986 Jan;45(1):19–24. [PubMed] [Google Scholar]
  24. Meyrick B. O., Reid L. M. Crotalaria-induced pulmonary hypertension. Uptake of 3H-thymidine by the cells of the pulmonary circulation and alveolar walls. Am J Pathol. 1982 Jan;106(1):84–94. [PMC free article] [PubMed] [Google Scholar]
  25. Meyrick B., Brigham K. L. Acute effects of Escherichia coli endotoxin on the pulmonary microcirculation of anesthetized sheep structure:function relationships. Lab Invest. 1983 Apr;48(4):458–470. [PubMed] [Google Scholar]
  26. Meyrick B., Gamble W., Reid L. Development of Crotalaria pulmonary hypertension: hemodynamic and structural study. Am J Physiol. 1980 Nov;239(5):H692–H702. doi: 10.1152/ajpheart.1980.239.5.H692. [DOI] [PubMed] [Google Scholar]
  27. Meyrick B., Perkett E. A., Brigham K. L. Inflammation and models of chronic pulmonary hypertension. Am Rev Respir Dis. 1987 Sep;136(3):765–767. doi: 10.1164/ajrccm/136.3.765. [DOI] [PubMed] [Google Scholar]
  28. PETERSON J. E. EFFECTS OF THE PYRROLIZIDINE ALKALOID, LASIOCARPINE N-OXIDE, ON NUCLEAR AND CELL DIVISION IN THE LIVER RATS. J Pathol Bacteriol. 1965 Jan;89:153–171. doi: 10.1002/path.1700890117. [DOI] [PubMed] [Google Scholar]
  29. Perkett E. A., Brigham K. L., Meyrick B. Increased vasoreactivity and chronic pulmonary hypertension following thoracic irradiation in sheep. J Appl Physiol (1985) 1986 Nov;61(5):1875–1881. doi: 10.1152/jappl.1986.61.5.1875. [DOI] [PubMed] [Google Scholar]
  30. Phillips P. G., Higgins P. J., Malik A. B., Tsan M. F. Effect of hyperoxia on the cytoarchitecture of cultured endothelial cells. Am J Pathol. 1988 Jul;132(1):59–72. [PMC free article] [PubMed] [Google Scholar]
  31. Plestina R., Stoner H. B. Pulmonary oedema in rats given monocrotaline pyrrole. J Pathol. 1972 Apr;106(4):235–249. doi: 10.1002/path.1711060405. [DOI] [PubMed] [Google Scholar]
  32. Rosen E. M., Vinter D. W., Goldberg I. D. Hypertrophy of cultured bovine aortic endothelium following irradiation. Radiat Res. 1989 Mar;117(3):395–408. [PubMed] [Google Scholar]
  33. Rosenberg H. C., Rabinovitch M. Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension. Am J Physiol. 1988 Dec;255(6 Pt 2):H1484–H1491. doi: 10.1152/ajpheart.1988.255.6.H1484. [DOI] [PubMed] [Google Scholar]
  34. TURNER J. H., LALICH J. J. EXPERIMENTAL COR PULMONALE IN THE RAT. Arch Pathol. 1965 Apr;79:409–418. [PubMed] [Google Scholar]
  35. Valdivia E., Lalich J. J., Hayashi Y., Sonnad J. Alterations in pulmonary alveoli after a single injection of monocrotaline. Arch Pathol. 1967 Jul;84(1):64–76. [PubMed] [Google Scholar]
  36. Wall R. T., Harlan J. M., Harker L. A., Striker G. E. Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res. 1980 Apr 1;18(1-2):113–121. doi: 10.1016/0049-3848(80)90175-9. [DOI] [PubMed] [Google Scholar]
  37. White I. N., Mattocks A. R. Reaction of dihydropyrrolizines with deoxyribonucleic acids in vitro. Biochem J. 1972 Jun;128(2):291–297. doi: 10.1042/bj1280291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. White S. M., Roth R. A. Pulmonary platelet sequestration is increased following monocrotaline pyrrole treatment of rats. Toxicol Appl Pharmacol. 1988 Dec;96(3):465–475. doi: 10.1016/0041-008x(88)90006-3. [DOI] [PubMed] [Google Scholar]
  39. Zoja C., Furci L., Ghilardi F., Zilio P., Benigni A., Remuzzi G. Cyclosporin-induced endothelial cell injury. Lab Invest. 1986 Oct;55(4):455–462. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES